SG11201912436PA - Method for predicting differentiation ability of pluripotent stem cell, and reagent for same - Google Patents

Method for predicting differentiation ability of pluripotent stem cell, and reagent for same

Info

Publication number
SG11201912436PA
SG11201912436PA SG11201912436PA SG11201912436PA SG11201912436PA SG 11201912436P A SG11201912436P A SG 11201912436PA SG 11201912436P A SG11201912436P A SG 11201912436PA SG 11201912436P A SG11201912436P A SG 11201912436PA SG 11201912436P A SG11201912436P A SG 11201912436PA
Authority
SG
Singapore
Prior art keywords
reagent
same
stem cell
pluripotent stem
differentiation ability
Prior art date
Application number
SG11201912436PA
Other languages
English (en)
Inventor
Shin Kawamata
Takako Yamamoto
Chiemi Takenaka
Original Assignee
Foundation For Biomedical Res And Innovation At Kobe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foundation For Biomedical Res And Innovation At Kobe filed Critical Foundation For Biomedical Res And Innovation At Kobe
Publication of SG11201912436PA publication Critical patent/SG11201912436PA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0607Non-embryonic pluripotent stem cells, e.g. MASC
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0696Artificially induced pluripotent stem cells, e.g. iPS
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073Stem cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
SG11201912436PA 2017-06-19 2018-06-04 Method for predicting differentiation ability of pluripotent stem cell, and reagent for same SG11201912436PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017120024 2017-06-19
JP2017237420 2017-12-12
PCT/JP2018/021430 WO2018235583A1 (ja) 2017-06-19 2018-06-04 多能性幹細胞の分化能の予測方法及びそのための試薬

Publications (1)

Publication Number Publication Date
SG11201912436PA true SG11201912436PA (en) 2020-01-30

Family

ID=64737514

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201912436PA SG11201912436PA (en) 2017-06-19 2018-06-04 Method for predicting differentiation ability of pluripotent stem cell, and reagent for same

Country Status (7)

Country Link
US (1) US20200172969A1 (ko)
EP (1) EP3643780A4 (ko)
JP (2) JP6736772B2 (ko)
KR (1) KR102422175B1 (ko)
CN (1) CN111164209A (ko)
SG (1) SG11201912436PA (ko)
WO (1) WO2018235583A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111164209A (zh) * 2017-06-19 2020-05-15 公益财团法人神户医疗产业都市推进机构 多能干细胞的分化能力的预测方法和用于该预测方法的试剂
EP3950933A4 (en) * 2019-03-29 2023-01-11 Kaneka Corporation CELL POPULATION COMPRISING PLURIPOTENT STEM CELLS AND METHOD FOR PRODUCING IT
WO2021085033A1 (ja) * 2019-10-28 2021-05-06 富士フイルム株式会社 多能性幹細胞の選別方法、分化誘導結果の予測方法及び細胞製品の製造方法
JP7138841B2 (ja) * 2019-11-15 2022-09-20 公立大学法人横浜市立大学 未分化マーカー遺伝子高感度検出法
EP4148139A4 (en) * 2020-06-19 2023-11-08 FUJIFILM Corporation METHOD FOR IDENTIFYING BIOMARKERS AND METHOD FOR PRODUCING CELLS
WO2023223447A1 (ja) * 2022-05-18 2023-11-23 株式会社日立製作所 予測装置、自動培養装置システム、予測方法およびキット

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
WO2005100548A1 (ja) 2004-03-30 2005-10-27 Kyoto University 精巣細胞由来多能性幹細胞の製造方法
EP2208786B1 (en) 2005-12-13 2018-08-01 Kyoto University Nuclear reprogramming factor
CN101743306A (zh) 2007-03-23 2010-06-16 威斯康星校友研究基金会 体细胞重编程
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
EP3078738B1 (en) 2007-08-31 2020-05-20 Whitehead Institute for Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
KR101564044B1 (ko) 2007-10-31 2015-10-28 고쿠리츠 다이가쿠 호진 교토 다이가쿠 핵초기화 방법
WO2009075119A1 (ja) 2007-12-10 2009-06-18 Kyoto University 効率的な核初期化方法
CA2709566A1 (en) 2007-12-17 2009-06-25 Gliamed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
EP2229444B1 (en) 2008-01-16 2019-10-30 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
US20110014164A1 (en) 2008-02-15 2011-01-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
CA2718904C (en) 2008-03-17 2017-01-03 The Scripps Research Institute Combined chemical and genetic approaches for generation of induced pluripotent stem cells
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
EP2274424A4 (en) 2008-04-07 2012-02-01 Nupotential Inc REPROGRAMMING A CELL BY INDUCING A PLURIPOTENT GENE USING AN HDAC MODULATOR
JP5340265B2 (ja) 2008-06-27 2013-11-13 国立大学法人京都大学 効率的な人工多能性幹細胞の樹立方法
WO2010009015A2 (en) 2008-07-14 2010-01-21 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/arid3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
US20120021519A1 (en) 2008-09-19 2012-01-26 Presidents And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
WO2010050626A1 (en) 2008-10-30 2010-05-06 Kyoto University Method for producing induced pluripotent stem cells
WO2010056831A2 (en) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
US9045737B2 (en) 2008-12-13 2015-06-02 Dnamicroarray, Inc. Artificial three-dimensional microenvironment niche culture
EP2401372A4 (en) 2009-02-27 2012-09-19 Univ Kyoto NEW NUCLEAR REPROGRAMMING SUBSTANCE
WO2010102267A2 (en) 2009-03-06 2010-09-10 Ipierian, Inc. Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US20120076762A1 (en) 2009-03-25 2012-03-29 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010115050A2 (en) 2009-04-01 2010-10-07 The Regents Of The University Of California Embryonic stem cell specific micrornas promote induced pluripotency
US20110088107A1 (en) 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
JP5682043B2 (ja) * 2009-09-02 2015-03-11 国立大学法人京都大学 安全な多能性幹細胞の選択方法
WO2012115270A1 (ja) * 2011-02-25 2012-08-30 学校法人慶應義塾 iPS細胞クローンの選択方法、及びその選択方法に用いる遺伝子の選択方法
CN103703130A (zh) * 2011-07-25 2014-04-02 国立大学法人京都大学 筛选诱导的多能干细胞的方法
US20140329704A1 (en) * 2013-03-28 2014-11-06 President And Fellows Of Harvard College Markers for mature beta-cells and methods of using the same
US20160264934A1 (en) * 2015-03-11 2016-09-15 The General Hospital Corporation METHODS FOR MODULATING AND ASSAYING m6A IN STEM CELL POPULATIONS
WO2017025061A1 (en) * 2015-08-13 2017-02-16 Peking University Induced extended pluripotent stem cells, methods of making and using
KR20170050916A (ko) * 2015-11-02 2017-05-11 연세대학교 산학협력단 유전자 구조 내 CpG 섬의 후성 유전학적 변형을 통한 줄기세포의 분화 조절 방법
JP2017120024A (ja) 2015-12-29 2017-07-06 肇 山口 道路上方設置型災害避難設備
CN111164209A (zh) 2017-06-19 2020-05-15 公益财团法人神户医疗产业都市推进机构 多能干细胞的分化能力的预测方法和用于该预测方法的试剂

Also Published As

Publication number Publication date
JP6736772B2 (ja) 2020-08-05
KR102422175B1 (ko) 2022-07-18
EP3643780A4 (en) 2021-04-07
KR20200015731A (ko) 2020-02-12
JPWO2018235583A1 (ja) 2020-04-16
JP7237890B2 (ja) 2023-03-13
US20200172969A1 (en) 2020-06-04
CN111164209A (zh) 2020-05-15
JP2020185000A (ja) 2020-11-19
WO2018235583A1 (ja) 2018-12-27
EP3643780A1 (en) 2020-04-29

Similar Documents

Publication Publication Date Title
SG11201912436PA (en) Method for predicting differentiation ability of pluripotent stem cell, and reagent for same
SG11202001914QA (en) Systems, methods and hydrogels for cell culture and analysis
IL256644B (en) A system and method for managing, performing and analyzing laboratory experiments
IL253829B (en) System and method for genetic analysis of isolated cells
LT3263715T (lt) Pavienių ląstelių transkriptomo analizės būdas
EP3267962A4 (en) System, method, and device for high-throughput, automated culturing of genetically modified organisms
SG11201701191WA (en) Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells
EP3369809A4 (en) Method for obtaining leydig cells by carrying out induced differentiation on human induced pluripotent stem cells, and use of leydig cells
IL287558B (en) A method for screening for stem cell differentiation agents
HK1257561A1 (zh) 永生化幹細胞及其製作方法
EP3438248A4 (en) CULTURAL MEDIUM OF NATIVE PLURIPOTENT STEM CELLS AND METHOD FOR CULTURING PLURIPOTENT STEM CELLS
EP3702444A4 (en) METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN HEPATOCYTE
GB201608060D0 (en) Method of culturing T cells
EP3578640A4 (en) DIFFERENTIATION CONTROL METHOD FOR PLURIPOTENT STEM CELLS
IL274746A (en) A method for cell culture
SG11201610878QA (en) Mutant hemagglutinin complex protein, and method for culturing pluripotent stem cells using same
EP3421598A4 (en) METHOD FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS BY REDUCING THEIR INDIFFERENTIATED STATE
EP3584307A4 (en) CELL CULTURE VESSEL, SAMPLE CELL FOR OBSERVATION AND CELL CULTURE PROCEDURE
GB201620195D0 (en) Electrochemical cell assembly and method for operation of the same
EP3561051A4 (en) COMPOSITION FOR PROMOTING PROLIFERATION OF PLURIPOTENT STEM CELLS, AND METHOD FOR PROMOTING PROLIFERATION OF PLURIPOTENT STEM CELLS
EP3399023A4 (en) METHOD FOR PROMOTING THE DIFFERENTIATION OF CULTURED CELLS AND CULTURED CELL DIFFERENTIATION PROMOTING THE MEDIUM
GB201620229D0 (en) Electrochemical cell assembly and method for operation of the same
EP3336178A4 (en) Method for culturing pluripotent stem cells, method for manufacturing culture vessel, culture vessel, and scaffold material for cell culturing
HK1254737A1 (zh) 幹細胞培養方法
EP3679160A4 (en) METHOD OF USING BIOMARKERS AND CLINICAL VARIABLES TO PREDICT THE INTEREST OF CHEMOTHERAPY